Muscle Proteomic Profile before and after Enzyme Replacement Therapy in Late-Onset Pompe Disease

Mutations in the acidic alpha-glucosidase (GAA) coding gene cause Pompe disease. Late-onset Pompe disease (LOPD) is characterized by progressive proximal and axial muscle weakness and atrophy, causing respiratory failure. Enzyme replacement therapy (ERT), based on recombinant human GAA infusions, is...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriggi, Manuela, Capitanio, Daniele, Torretta, Enrica, Barbacini, Pietro, Bragato, Cinzia, Sartori, Patrizia, Moggio, Maurizio, Maggi, Lorenzo, Mora, Marina, Gelfi, Cecilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001152/
https://www.ncbi.nlm.nih.gov/pubmed/33799647
http://dx.doi.org/10.3390/ijms22062850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001152/
https://www.ncbi.nlm.nih.gov/pubmed/33799647
http://dx.doi.org/10.3390/ijms22062850

Ejemplares similares